ArticleSurgical endoscopy2025
Vacuum-assisted self-expanding stents in colorectal surgery: early experiences with a novel tool.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Treatment of colorectal leaks with the VACStent-Colon: results of the VACStent feasibility trial.Surgical endoscopy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAnastomotic leakage (AL) remains a dreaded complication following colorectal resections. The routine use of diverting loop ileostomies (DLI), is associated with significant morbidity, triggering interest in alternative strategies. The VACStent Colon (VSC), a novel endoscopic treatment, combines vacuum-assisted closure with a self-expanding stent, providing luminal patency. Here we report our 1-year experience with the VSC.
methodsRetrospective analysis of patients treated with VSC at our department from 02/2024 to 03/2025 either therapeutically for AL or prophylactically in high-risk anastomoses. Outcomes, including continuous luminal patency by VSC, AL healing, complications, and need for DLI, were assessed with follow-up until endoscopic healing (EH) of AL.
resultsThirteen patients received a total of 47 VSC. Continuous luminal patency was achieved in 89.4%. Overall, 10 patients were treated with therapeutic intent (43 VSC). Nine patients achieved EH under VSC therapy (6 with DLI close, 2 awaiting DLI, one managed without DLI). One patient did not achieve EH. Three patients underwent prophylactic VSC therapy following high-risk anastomoses without a DLI. Notably, no AL occurred in this group. The most commonly observed complication was pain, particularly in distally placed VSC. Outpatient VSC therapy was successfully implemented in select cases.
conclusionVSC shows promising results as therapeutic tool for treating colorectal AL and as prophylactic measure in high-risk anastomoses. It offers the benefits of vacuum therapy combined with mechanical stenting providing luminal patency, potentially reducing the need for DLI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.